Results 201 to 210 of about 46,059 (254)

Advances in the treatment of malignant tumors with neurological drugs. [PDF]

Discov Oncol
Li Y, Na J, Zhong L, Zhao Y.
europepmc   +1 more source

A difference between cytosolic Ca2+ concentration-tension relationship for norepinephrine and that for clonidine, alpha-l-adrenergic partial agonist in rabbit aorta

, 1990
Shuji Onozuka, Issei Takayanagi
openalex   +1 more source

Adrenergic blockers, statins, and non-steroidal anti-inflammatory drugs are associated with later age at onset in Parkinson's disease. [PDF]

J Neurol
Malatt C, Maghzi H, Hogg E, Tan E, Khatiwala I, Tagliati M.   +5 more
europepmc   +1 more source

Berberine ameliorates acute hyperglycemia and hypoinsulinemia induced by ketamine/xylazine in rats: role of alpha₂ adrenergic receptors, oxidative stress and inflammatory suppressing mechanisms. [PDF]

BMC Vet Res
Kadhim RA, Erfanparast A, Tamaddonfard E, Amirkashani D, Imani M.   +4 more
europepmc   +1 more source

Perioperative Management of Paediatric Hypertension. [PDF]

Children (Basel)
Barbosa N, Redelinghuys C, Mogane P.
europepmc   +1 more source

Alpha-methylnorepinephrine, a selective alpha2-adrenergic agonist for cardiac resuscitation

, 2001
Shijie Sun, Max Harry Weil, Wanchun Tang, Takashi Kamohara, Kada Klouche   +4 more
openalex   +1 more source

REPEATED EXPOSURE TO AN ALPHA-ADRENERGIC RECEPTOR AGONIST INDUCES AN ENDOTHELIAL FACTOR THAT ALTERS VESSEL CONTRACTIONS TO THAT AGONIST.

, 2001
P. D. Harris, Jing Hu, Touichi Kawabe, R. Neal Garrison   +3 more
openalex   +1 more source

Beta adrenergic signaling as a therapeutic target for autoimmunity. [PDF]

J Neuroimmunol
Lauten TH, Reed EC, Natour T, Pitts LJ, Jojo CN, Griffin BL, Case AJ.   +6 more
europepmc   +1 more source

Neuroprotection in Parkinson Disease. [PDF]

Neurol Ther
Gonzalez-Robles C, Bandmann O, Schapira AHV.   +2 more
europepmc   +1 more source

<i>Acridocarpus smeathmannii</i> root extracts inhibit human prostate and bladder smooth muscle contraction, porcine arterial vasoconstriction, and cytotoxicity of prostate stromal cells. [PDF]

Front Pharmacol
Kale OE, Hu S, Huber C, Schierholz F, Ciotkowska A, Tamalunas A, Stief CG, Eisenreich W, Hennenberg M.   +8 more
europepmc   +1 more source